Cubist Systematic Strategies, LLC Cor Medix Inc. Transaction History

Cubist Systematic Strategies, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$3.0 - $4.01 $13,470 - $18,004	4,490 Added 35.16%	17,259 $64,000
Q3 2023 Nov 14, 2023	BUY	$3.6 - $4.46 $45,968 - $56,949	12,769 New	12,769 $47,000
Q1 2023 May 15, 2023	BUY	$3.22 - $4.61 $93,515 - $133,883	29,042 New	29,042 $120,000
Q3 2022 Nov 14, 2022	SELL	$2.82 - $7.52 $29,048 - $77,463	-10,301 Reduced 26.89%	28,000 $79,000
Q2 2022 Aug 15, 2022	BUY	$2.73 - $5.61 $104,561 - $214,868	38,301 New	38,301 $154,000

104

17.4M

134K

441K

Ticker CRMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,208,200
Market Cap $426M
Description
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of cathet...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.